APTO
Price:
$1.71
Market Cap:
$4.36M
Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates. APTO-253 is currently undergoing Phase 1a/b clinical evaluation for patients battling relapsed or treatment-resistant blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another compound, HM43239, is progressing through Phase 1/2 clinical trials, specifically targeting individuals with relapsed or refract...[Read more]
Industry
Biotechnology
IPO Date
1992-03-16
Stock Exchange
NASDAQ
Ticker
APTO
According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.42M. This represents a change of -16.47% compared to the average of 4.10M of the last 4 quarters.
The mean historical Enterprise Value of Aptose Biosciences Inc. over the last ten years is 1.49B. The current 3.42M Enterprise Value has changed -77.07% with respect to the historical average. Over the past ten years (40 quarters), APTO's Enterprise Value was at its highest in in the March 2021 quarter at 7.90B. The Enterprise Value was at its lowest in in the March 2026 quarter at 3.42M.
Average
1.49B
Median
753.07M
Minimum
3.44M
Maximum
5.73B
Discovering the peaks and valleys of Aptose Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 344.87%
Maximum Annual Enterprise Value = 5.73B
Minimum Annual Increase = -93.19%
Minimum Annual Enterprise Value = 3.44M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.44M | -90.02% |
| 2024 | 34.51M | -93.19% |
| 2023 | 506.49M | -33.97% |
| 2022 | 767.06M | -56.53% |
| 2021 | 1.76B | -69.22% |
| 2020 | 5.73B | 36.93% |
| 2019 | 4.19B | 344.87% |
| 2018 | 941.35M | 27.37% |
| 2017 | 739.09M | 186.74% |
| 2016 | 257.75M | -41.89% |
The current Enterprise Value of Aptose Biosciences Inc. (APTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
181.48M
5-year avg
615.25M
10-year avg
1.49B
Aptose Biosciences Inc.’s Enterprise Value is less than Gamida Cell Ltd. (40.73M), greater than Rubius Therapeutics, Inc. (-13765000.00), greater than Idera Pharmaceuticals, Inc. (-11484000.00), greater than Nabriva Therapeutics plc (-7192677.00), less than Atreca, Inc. (36.62M), less than Gritstone bio, Inc. (43.29M), greater than Aravive, Inc. (-44467140.00), less than RVL Pharmaceuticals plc (16.09M), less than Oncorus, Inc. (42.71M), greater than Affimed N.V. (-19176588.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 40.73M | $4.34M | |
| -13765000.00 | $0 | |
| -11484000.00 | $0 | |
| -7192677.00 | $323.00 | |
| 36.62M | $3.57M | |
| 43.29M | $3.80M | |
| -44467140.00 | $2.95M | |
| 16.09M | $3.14M | |
| 42.71M | $0 | |
| -19176588.00 | $2.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Aptose Biosciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Aptose Biosciences Inc. (APTO)?
What is the 3-year average Enterprise Value for Aptose Biosciences Inc. (APTO)?
What is the 5-year average Enterprise Value for Aptose Biosciences Inc. (APTO)?
How does the current Enterprise Value for Aptose Biosciences Inc. (APTO) compare to its historical average?